Two distinct arsenite-resistant variants of Leishmania amazonensis take different routes to achieve resistance as revealed by comparative transcriptomics.
Genome-wide search for the genes involved in arsenite resistance in two distinct variants A and A' of Leishmania amazonensis revealed that the two variants used two different mechanisms to achieve resistance, even though these two variants were derived from the same clone and selected against arsenite under the same conditions. In variant A, the variant with DNA amplification, the biochemical pathways for detoxification of oxidative stress, the energy generation system to support the biochemical and physiological needs of the variant for DNA and protein synthesis and the arsenite translocating system to dispose arsenite are among the primary biochemical events that are upregulated under the arsenite stress to gain resistance. In variant A', the variant without DNA amplification, the upregulation of aquaglyceroporin (AQP) gene and the high level of resistance to arsenate point to the direction that the resistance gained by the variant is due to arsenate which is probably oxidized from arsenite in the arsenite solution used for selection and the maintenance of the cell culture. As a result of the AQP upregulation for arsenite disposal, a different set of biochemical pathways for detoxification of oxidative stress, energy generation and cellular signaling are upregulated to sustain the growth of the variant to gain resistance to arsenate. From current evidences, reactive oxygen species (ROS) overproduced by the parasite soon after exposure to arsenite appear to play an instrumental role in both variants to initiate the subsequent biochemical events that allow the same clone of L. amazonensis to take two totally different routes to diverge into two different variants.
Lin
Yi-Chun
YC
Division of Infectious Diseases, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC.
Hsu
Ju-Yu
JY
Shu
Jui-Hsu
JH
Chi
Yi
Y
Chiang
Su-Chi
SC
Lee
Sho Tone
ST
D000818:Animals; D051397:Aquaglyceroporins / Q000235:genetics / Q000378:metabolism; D001149:Arsenates / Q000378:metabolism / Q000494:pharmacology; D018053:Arsenites / Q000378:metabolism / Q000494:pharmacology*; D003001:Cloning, Molecular; D019295:Computational Biology / Q000379:methods; D004351:Drug Resistance / Q000235:genetics*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D014644:Genetic Variation; D007891:Leishmania / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D009693:Nucleic Acid Hybridization / Q000379:methods; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D021261:Parasitic Sensitivity Tests; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism; D017422:Sequence Analysis, DNA; D015854:Up-Regulation
D051397:Aquaglyceroporins; D001149:Arsenates; D018053:Arsenites; D015800:Protozoan Proteins; D017382:Reactive Oxygen Species; C015001:arsenite; C025657:arsenic acid